바이킹 테라퓨틱스(Viking Therapeutics, Inc.)
US ˙ NasdaqCM ˙ US92686J1060

SecurityVKTX / Viking Therapeutics, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC ownership in VKTX / Viking Therapeutics, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Viking Therapeutics, Inc. (US:VKTX) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 15, 2022 disclosing 14,624 shares of Viking Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (VKTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VKTX / Viking Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 0 -14,624 -100.00 0 -100.00
2022-11-14 2022-09-30 13F VIKING THERAPEUTICS COM 92686J106 0 -14,624 0
2022-08-15 2022-06-30 13F VIKING THERAPEUTICS COM 92686J106 14,624 14,624 6 0.0000
2020-11-02 2020-06-30 13F/A-1 VIKING THERAPEUTICS COM 92686J106 0 -1,627 -100.00 0 -100.00
2020-05-15 2020-03-31 13F VIKING THERAPEUTICS COM 92686J106 1,627 -52,500 -96.99 8 -98.16 0.0001
2020-02-13 2019-12-31 13F VIKING THERAPEUTICS COM 92686J106 54,127 -7,470 -12.13 434 2.36 0.0034
2019-11-13 2019-09-30 13F VIKING THERAPEUTICS COM 92686J106 61,597 6,986 12.79 424 -6.40 0.0033
2019-08-14 2019-06-30 13F VIKING THERAPEUTICS COM 92686J106 54,611 23,139 73.52 453 44.73 0.0033
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM 92686J106 31,472 -23,002 -42.23 313 -24.94 0.0026
2019-02-14 2018-12-31 13F VIKING THERAPEUTICS COM 92686J106 54,474 49,889 1,088.09 417 421.25 0.0034
2018-11-14 2018-09-30 13F VIKING THERAPEUTICS COM 92686J106 4,585 4,585 80 0.0005
2018-08-14 2018-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -20,300 -100.00 0 -100.00
2018-05-15 2018-03-31 13F VIKING THERAPEUTICS COM 92686J106 20,300 20,300 89 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2021-03-31 13F/A VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F VIKING THERAPEUTICS COM Call 0 0 n/a n/a n/a
2023-09-21 2020-12-31 13F/A VIKING THERAPEUTICS COM Call 24,000 135 n/a n/a n/a
2021-02-16 2020-12-31 13F VIKING THERAPEUTICS COM Call 24,000 135 n/a n/a n/a
2020-11-13 2020-09-30 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-02 2020-06-30 13F/A VIKING THERAPEUTICS COM Call 50,000 0.00 361 54.27 n/a n/a n/a
2020-08-14 2020-06-30 13F VIKING THERAPEUTICS COM Call 50,000 361 n/a n/a n/a
2020-05-15 2020-03-31 13F VIKING THERAPEUTICS COM Call 50,000 234 n/a n/a n/a
2019-08-14 2019-06-30 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM Call 85,400 849 n/a n/a n/a
2019-02-14 2018-12-31 13F VIKING THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F VIKING THERAPEUTICS COM Call 116,200 26.30 2,024 131.84 n/a n/a n/a
2018-08-14 2018-06-30 13F VIKING THERAPEUTICS COM Call 92,000 873 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F VIKING THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F VIKING THERAPEUTICS COM Put 52,500 0.00 421 16.62 n/a n/a n/a
2019-11-13 2019-09-30 13F VIKING THERAPEUTICS COM Put 52,500 0.00 361 -17.20 n/a n/a n/a
2019-08-14 2019-06-30 13F VIKING THERAPEUTICS COM Put 52,500 0.00 436 -16.48 n/a n/a n/a
2019-05-15 2019-03-31 13F VIKING THERAPEUTICS COM Put 52,500 31.25 522 70.59 n/a n/a n/a
2019-02-14 2018-12-31 13F VIKING THERAPEUTICS COM Put 40,000 -20.63 306 -65.15 n/a n/a n/a
2018-11-14 2018-09-30 13F VIKING THERAPEUTICS COM Put 50,400 384.62 878 786.87 n/a n/a n/a
2018-08-14 2018-06-30 13F VIKING THERAPEUTICS COM Put 10,400 99 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.